Related Experiment Videos
Potential drug interaction between simvastatin and danazol causing rhabdomyolysis
E Roseann Andreou1, Séadna Ledger
1Department of Medicine, London Health Sciences Centre, Ontario.
Summary
Rhabdomyolysis, a severe muscle injury, can rarely occur with statins. Combining simvastatin with danazol led to rhabdomyolysis and acute kidney failure in a patient.
Area of Science:
- Biochemistry
- Pharmacology
- Nephrology
Background:
- Rhabdomyolysis is a critical condition involving skeletal muscle damage.
- Hydroxymethylglutaryl coenzyme A reductase inhibitors (statins) are widely used for dyslipidemia.
- Statins are associated with myopathy and, rarely, rhabdomyolysis.
Observation:
- Statins can cause rhabdomyolysis alone or when combined with myotoxic drugs.
- Drug interactions can increase statin concentration due to CYP450 metabolism and low oral bioavailability.
- A case of rhabdomyolysis and acute renal failure was observed.
Findings:
- The observed rhabdomyolysis and acute renal failure were secondary to an interaction between danazol and simvastatin.
- This case highlights the potential dangers of combining certain medications with statins.
Implications:
- Clinicians must be aware of the risk of rhabdomyolysis with statin therapy, especially in combination regimens.
- Understanding drug interactions is crucial for preventing rare but severe adverse events like statin-induced rhabdomyolysis.
- This emphasizes the need for careful patient monitoring when prescribing statins with potentially interacting medications.